Literature DB >> 9730436

Testosterone replacement therapy.

E Velázquez1, G Bellabarba Arata.   

Abstract

The benefits conferred by testosterone replacement therapy are substantial, both in the short term for the eradication of symptoms of androgen deficiency, and in the long term for the prevention of osteoporosis. As with any long-term treatment there are risks that must be considered, but overall the benefits achieved far outweigh potential risk. Ideally, androgen replacement therapy should provide physiological serum testosterone levels, as well as DHT and estradiol levels, and correct the clinical symptoms of androgen deficiency in hypogonadal men. This goal is difficult to achieve because the dose dependency of androgen-dependent physiological processes is not known. Androgen preparations that are currently available do not fulfill all criteria for an ideal androgen replacement therapy. Parenteral testosterone esters are effective, safe, practical, and inexpensive. The transdermal testosterone systems provide an alternative to testosterone esters in selected patients but these preparations are expensive. Ongoing studies are showing the benefits of testosterone replacement therapy in aging men, but there is concern about side effects on cardiovascular system and prostate. Thus, clinical decision regarding testosterone therapy in older men should be better defined.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9730436     DOI: 10.3109/01485019808987949

Source DB:  PubMed          Journal:  Arch Androl        ISSN: 0148-5016


  2 in total

1.  Changes in Sexual Behavior of Orchidectomized Rats Under Influence of Allotransplantation of Testicular Interstitial Cell Suspension.

Authors:  Bo Deng; Tatyana Bondarenko; Oleksandr Pakhomov
Journal:  Cell Transplant       Date:  2016-09-30       Impact factor: 4.064

2.  Pharmacokinetics of S-3-(4-acetylamino-phenoxy)-2-hydroxy-2-methyl-N-(4-nitro- 3-trifluoromethyl-phenyl)-propionamide in rats, a non-steroidal selective androgen receptor modulator.

Authors:  J D Kearbey; D Wu; W Gao; D D Miller; J T Dalton
Journal:  Xenobiotica       Date:  2004-03       Impact factor: 1.908

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.